Distinguished in Selective Mutism

Wei Z. Yang

Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
Distinguished in Selective Mutism
Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Wei Yang practices in Beijing, China. Dr. Yang is rated as a Distinguished expert by MediFind in the treatment of Selective Mutism. Their top areas of expertise are Liver Cancer, Selective Mutism, Gliomatosis Cerebri, Vagotomy, and Cardiac Ablation.

Their clinical research consists of co-authoring 3184 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Selective Mutism.

Locations

Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
Other Locations
No. 300 Guangzhou Road, Nanjing, 210029, China
36 San Hao Street, Shenyang, 110004, China
State Key Laboratory Of Materials Oriented Chemical Engineering, Nanjing, 211816, China
9 West Lvshun South Road, Dalian, 116044, China
1035 Boshuo Road, Changchun, China
Union Hospital, Wuhan, 430022, China
No. 759, East 2nd Road, Huzhou, 313000, China
No. 320, Changcheng North Street, Baoding, 071000, China
Jiangsu Key Laboratory For Eco Agricultural Biotechnology Around Hongze Lake, Chaigoubu, China
National Forestry And Grassland Administration Key Laboratory Of Forest Resources Conservation And Ecological Safety On The Upper Reaches Of The Yangtze River, Chengdu, 611130, China
804 Shengli Road, Yinchuan, 750004, China
No. 1 Fuwai Road, Zhengzhou, 451464, China
No.277 Yanta West Road, Xi'an, 710061, China
277 Yanta West Road, Xi'an, 710061, China
1665 Kongjiang Road, Shanghai, 200092, China
No. 127 Dongming Rd, Zhengzhou, 450008, China
127 Dongming Road, Zhengzhou, China
Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, 100730, China
No. 1, Minde Road, Nanchang, 330006, China
No. 189, Chaoyang Road, Kunshan, 215300, China
39 Huaxiang Road, Shenyang, 110000, China
No. 28 Fuxing Road, Haidian, 100853, China
1095 JieFang Avenue, Wuhan, 430030, China
208 Huancheng East Road, Hangzhou, 310003, China
72 Wenhua Road, Shenyang, 110016, China
China Japan Union Hospital of Jilin University
Changchun, 130000, China
No.6, Xinhe Road, Quzhou, 324000, China
56 Nanlishi Road, Beijing, 100045, China
Xinyang Rd. 2, Daqing, 163319, China
No. 9677 Jingshi Road, Jinan, 250014, China
No. 1 Xinqiaoyuan Road, Guilin, 541002, China
274 Zhijiang Road, Shanghai, 200071, China
37 Yiyuan Street, Harbin, 150001, China
66 Changjiang West Road, Qingdao, 266580, China
129 Luoyu Road, Wuhan, 430079, China
No. 45 Chang Chun Street, Beijing, 100053, China
JieFang Avenue, Wuhan, China
218 Ziqiang Street, Changchun, 130041, China
No.164, LanXi Road, Shanghai, 200063, China
56 Xinjian South Road, Taiyuan, 030001, China
NO. 1 Daxue Road, Xuzhou, 221000, China
158 Shangtang Road, Hangzhou, 310014, China
Tianjin Key Laboratory Of Molecular Drug Research, Tianjin, China
No185, Juqian Street, Changzhou, 213003, China
China P.R, Changchun, 130118, China
126 Xinmin Avenue, Changchun, 130021, China
Huaxiang Road 39, Shenyang, 110000, China
13 Hangkong Road, Wuhan, 430030, China
23 Youzheng Street, Harbin, 150001, China
Jiefang Road 1095, Wuhan, 430030, China
Changjiang West Road, Qingdao, 266580, China
100 Kexue Road, Zhengzhou, 450001, China
180 Si Wang Ting Road, Yangzhou, 225002, China
No. 199 Renai Road, Suzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)
Enrollment Status: Active_not_recruiting
Publish Date: May 28, 2025
Intervention Type: Drug
Study Drugs: LOXO-305, Ibrutinib, Acalabrutinib, Zanubrutinib
Study Phase: Phase 3
A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate Tablets
Study Phase: Phase 3
A Phase 3, Randomized, Controlled, Open-label, Clinical Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Patients With Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Low-Blast Acute Myelogenous Leukemia
A Phase 3, Randomized, Controlled, Open-label, Clinical Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Patients With Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Low-Blast Acute Myelogenous Leukemia
Enrollment Status: Completed
Publish Date: October 28, 2024
Intervention Type: Drug
Study Drugs: Azacitidine, Pevonedistat
Study Phase: Phase 3
View 2 Less Clinical Trials

3174 Total Publications

Local Microenvironment-Induced Dynamic Self-Adaptation for High-Performance Ammonium-Ion Batteries.
Local Microenvironment-Induced Dynamic Self-Adaptation for High-Performance Ammonium-Ion Batteries.
Journal: ACS nano
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yang's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 85 Advanced Conditions
    View All 327 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile